Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hyperplasia that involves the adrenal medulla.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for adrenal medullary hyperplasia.
4 publications have been identified in PubMed for adrenal medullary hyperplasia. Research spans Case Report / Case Series (100%).
de Oliveira WL (2025). [PMID: 40476723](https://pubmed.ncbi.nlm.nih.gov/40476723/). *Endocrinology, diabetes & metabolism case reports*. [Case Report / Case Series]
Kats MV (2025). [PMID: 41235518](https://pubmed.ncbi.nlm.nih.gov/41235518/). *Terapevticheskii arkhiv*. [Case Report / Case Series]
Hu X (2025). [PMID: 40702712](https://pubmed.ncbi.nlm.nih.gov/40702712/). *The American journal of case reports*. [Case Report / Case Series]
Ozercan AY (2024). [PMID: 37987635](https://pubmed.ncbi.nlm.nih.gov/37987635/). *Minerva urology and nephrology*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC
European rare disease database
Common questions about adrenal medullary hyperplasia